Mark E Delaney Quest Diagnostics Inc (DGX) insider trading activity

Mark E Delaney is SVP & Chief Commercial Officer of QUEST DIAGNOSTICS INC. Currently has a direct ownership of 9,221 shares of DGX, which is worth approximately $1.26 Million. The most recent transaction as insider was on Mar 26, 2025, when has been sold 256 shares (Common Stock) at a price of $166.71 per share, resulting in proceeds of $42,677. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.22K

83.58% 3M change

69.72% 12M change

Total Value Held $1.26 Million

MARK E DELANEY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 26 2025	SELL Payment of exercise price or tax liability	$42,677 $166.71 p/Share	256 Reduced 2.7%	9,221 Common Stock
Mar 04 2025	SELL Payment of exercise price or tax liability	$316,728 $173.74 p/Share	1,823 Reduced 16.13%	9,477 Common Stock
Mar 04 2025	BUY Grant, award, or other acquisition	$923,775 $173.74 p/Share	5,317 Added 32.0%	11,300 Common Stock
Feb 26 2025	SELL Payment of exercise price or tax liability	$36,754 $171.75 p/Share	214 Reduced 3.45%	5,983 Common Stock
Feb 19 2025	SELL Payment of exercise price or tax liability	$41,069 $169.71 p/Share	242 Reduced 3.76%	6,197 Common Stock
Feb 12 2025	BUY Grant, award, or other acquisition	-	1,815 Added 21.99%	6,439 Common Stock
Feb 05 2025	SELL Open market or private sale	$66,212 $164.3 p/Share	403 Reduced 8.02%	4,624 Common Stock
Jan 29 2025	BUY Small Acquisition	$632 $158.03 p/Share	4 Added 0.08%	5,027 Common Stock
Oct 21 2024	BUY Small Acquisition	$597 $149.39 p/Share	4 Added 0.08%	5,023 Common Stock
Jul 24 2024	SELL Open market or private sale	$60,093 $143.08 p/Share	420 Reduced 7.72%	5,019 Common Stock
Jul 22 2024	BUY Small Acquisition	$881 $146.98 p/Share	6 Added 0.11%	5,439 Common Stock
Mar 26 2024	SELL Payment of exercise price or tax liability	$21,778 $128.11 p/Share	170 Reduced 3.03%	5,433 Common Stock
Feb 28 2024	SELL Payment of exercise price or tax liability	$28,431 $126.36 p/Share	225 Reduced 3.86%	5,603 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	2,348 Added 28.72%	5,828 Common Stock
Mar 24 2023	SELL Payment of exercise price or tax liability	$22,822 $134.25 p/Share	170 Reduced 4.66%	3,480 Common Stock
Feb 23 2023	BUY Grant, award, or other acquisition	-	1,919 Added 34.46%	3,650 Common Stock

MED

Mark E Delaney

SVP & Chief Commercial Officer

Secaucus, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DGX shares.

Notify only if

Value

Insider Trading

Get notified when an Quest Diagnostics Inc insider buys or sells DGX shares.

Notify only if

Operation

Value

Type

News

Receive news related to QUEST DIAGNOSTICS INC

Track Activities on DGX

Account